Clinical MedicineIn-Press PreviewCardiologyNephrology
Open Access | 10.1172/jci.insight.165172
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by Chatterjee, E. in: JCI | PubMed | Google Scholar
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Rodosthenous, R.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by Kujala, V. in: JCI | PubMed | Google Scholar
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Gokulnath, P.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Spanos, M.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Lehmann, H.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Oliveira-Jr, G.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Shi, M.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Miller-Fleming, T.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Li, G.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Ghiran, I.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Karalis, K.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by Lindenfeld, J. in: JCI | PubMed | Google Scholar
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Mosley, J.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Lau, E.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Ho, J.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Sheng, Q.
in:
JCI
|
PubMed
|
Google Scholar
|
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by Shah, R. in: JCI | PubMed | Google Scholar
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, United States of America
2Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
3Discovery Biology, Emulate, Inc., Boston, United States of America
4Cardiovascular Research Center, Harvard Medical School, Boston, United States of America
5Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, United States of America
6Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, United States of America
7Department of Medicine, Vanderbilt University Medical Center, Nashville, United States of America
8RGC, Regeneron, Regeneron Pharmaceuticals, Inc, Tarrytown, United States of America
9Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, United States of America
11Cardiology Division, Vanderbilt University Medical Center, Nashville, United States of America
Find articles by
Das, S.
in:
JCI
|
PubMed
|
Google Scholar
|
Published September 14, 2023 - More info
Background: Cardiorenal syndrome (CRS)—renal injury during heart failure (HF)—is linked to higher morbidity. Whether circulating extracellular vesicles (EVs) and their RNA cargo directly impact its pathogenesis remains unclear. Methods: We investigated the role of circulating EVs from patients with CRS on renal epithelial/endothelial cells using a microfluidic kidney-on-chip model (KOC). The small RNA cargo of circulating EVs was regressed against serum creatinine to prioritize subsets of functionally relevant EV miRNAs and their mRNA targets investigated using in silico pathway analysis, human genetics, and interrogation of expression in the KOC model and in renal tissue. The functional effects of EV-RNAs on kidney epithelial cells were experimentally validated.Results: Renal epithelial and endothelial cells in the KOC model exhibited uptake of EVs from HF patients. HF-CRS EVs led to higher expression of renal injury markers (IL18, LCN2, HAVCR1) relative to non-CRS EVs. 15 EV-miRNAs were associated with creatinine, targeting 1143 gene targets specifying pathways relevant to renal injury, including TGF beta and AMPK signaling. We observed directionally consistent changes in the expression of TGF beta pathway members (BMP6, FST, TIMP3) in the KOC model exposed to CRS EVs, which were validated in epithelial cells treated with corresponding inhibitors and mimics of miRNAs. A similar trend was observed in renal tissue with kidney injury. Mendelian randomization suggested a role for FST in renal function. Conclusion: Plasma EVs in CRS patients elicit adverse transcriptional and phenotypic responses in a KOC model by regulating biologically relevant pathways, suggesting a role for EVs in CRS.